Chlorphenesin Carbamate
A centrally acting skeletal muscle relaxant related to mephenesin, historically used for the relief of acute musculoskeletal pain and discomfort. Its mechanism involves depression of polysynaptic reflexes in the spinal cord. It has largely fallen out of use in favor of other muscle relaxants with better-characterized safety profiles.
Peso molecular
245,6600 g/mol
LogP
1,20
TPSA
81,80 Ų
Regla de cinco de Lipinski
Cumple
Áreas terapéuticas
Mecanismo de acción
Reduces skeletal muscle tone and spasm through central or peripheral mechanisms, typically by modulating spinal reflexes, enhancing inhibitory neurotransmission, or blocking neuromuscular transmission.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Reduces skeletal muscle tone and spasm through central or peripheral mechanisms, typically by modulating spinal reflexes, enhancing inhibitory neurotransmission, or blocking neuromuscular transmission.
Estructura 2D
Cite this structure
Embed this structure
SMILES
NC(=O)OCC(O)COc1ccc(Cl)cc1
InChI
InChI=1S/C10H12ClNO4/c11-7-1-3-9(4-2-7)15-5-8(13)6-16-10(12)14/h1-4,8,13H,5-6H2,(H2,12,14)
Molecular Formula
C10H12ClNO4
HBD / HBA
2 / 4
Enlaces Rotables
6
Átomos Pesados
16
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Preguntas frecuentes
A centrally acting skeletal muscle relaxant related to mephenesin, historically used for the relief of acute musculoskeletal pain and discomfort. Its mechanism involves depression of polysynaptic reflexes in the spinal cord. It has largely fallen out of use in favor of other muscle relaxants with better-characterized safety profiles.
Reduces skeletal muscle tone and spasm through central or peripheral mechanisms, typically by modulating spinal reflexes, enhancing inhibitory neurotransmission, or blocking neuromuscular transmission.
Yes, Chlorphenesin Carbamate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL607710. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 2724. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="chlorphenesin-carbamate"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/chlorphenesin-carbamate/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/chlorphenesin-carbamate/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/chlorphenesin-carbamate/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="chlorphenesin-carbamate"></drugfyi-drug>